152 related articles for article (PubMed ID: 16522587)
1. Are development times for pharmaceuticals increasing or decreasing?
Keyhani S; Diener-West M; Powe N
Health Aff (Millwood); 2006; 25(2):461-8. PubMed ID: 16522587
[TBL] [Abstract][Full Text] [Related]
2. Economics of new oncology drug development.
DiMasi JA; Grabowski HG
J Clin Oncol; 2007 Jan; 25(2):209-16. PubMed ID: 17210942
[TBL] [Abstract][Full Text] [Related]
3. New drug approval times and 'therapeutic potential' in Canada, Australia, Sweden and the United States during the period 1992 to 1998.
Rawson NS; Kaitin KI
Can J Clin Pharmacol; 2000; 7(2):97-101. PubMed ID: 10958705
[TBL] [Abstract][Full Text] [Related]
4. Cutting the cost of drug development?
Rawlins MD
Nat Rev Drug Discov; 2004 Apr; 3(4):360-4. PubMed ID: 15060531
[No Abstract] [Full Text] [Related]
5. Changing requirements for evaluation of pharmacologic agents.
Chesney RW; Christensen ML
Pediatrics; 2004 Apr; 113(4 Suppl):1128-32. PubMed ID: 15060209
[TBL] [Abstract][Full Text] [Related]
6. Trends in development and approval times for new therapeutics in the United States.
Reichert JM
Nat Rev Drug Discov; 2003 Sep; 2(9):695-702. PubMed ID: 12951576
[TBL] [Abstract][Full Text] [Related]
7. Assessing prescription medications for priority regulatory review.
Rawson NS
Regul Toxicol Pharmacol; 2005 Jun; 42(1):70-6. PubMed ID: 15896445
[TBL] [Abstract][Full Text] [Related]
8. Development of paediatric medicines: concepts and principles.
Rose K; Della Pasqua O
Handb Exp Pharmacol; 2011; 205():111-24. PubMed ID: 21882108
[TBL] [Abstract][Full Text] [Related]
9. New estimates of drug development costs.
Frank RG
J Health Econ; 2003 Mar; 22(2):325-30. PubMed ID: 12606149
[No Abstract] [Full Text] [Related]
10. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
11. Clinical development and review times for new drugs in Japan: associated factors.
Ishibashi T; Yasuda K; Kusama M; Sugiyama Y; Ono S
Clin Pharmacol Ther; 2010 Oct; 88(4):487-91. PubMed ID: 20739921
[TBL] [Abstract][Full Text] [Related]
12. Non-clinical Post-Marketing Commitments for newly licenced pharmaceuticals.
Reeve LM
Regul Toxicol Pharmacol; 2009 Nov; 55(2):181-7. PubMed ID: 19589365
[TBL] [Abstract][Full Text] [Related]
13. New drug approval times and clinical evidence in Japan.
Ono S; Yoshioka C; Asaka O; Tamura K; Shibata T; Saito K
Contemp Clin Trials; 2005 Dec; 26(6):660-72. PubMed ID: 16122988
[TBL] [Abstract][Full Text] [Related]
14. Exploring differences in drug doses between Japan and Western countries.
Arnold FL; Kusama M; Ono S
Clin Pharmacol Ther; 2010 Jun; 87(6):714-20. PubMed ID: 20410879
[TBL] [Abstract][Full Text] [Related]
15. [Development of new drugs is too expensive].
Andreasen J
Ugeskr Laeger; 2003 May; 165(19):1959-60. PubMed ID: 12795066
[No Abstract] [Full Text] [Related]
16. Medicine. A portfolio model of drug development for tuberculosis.
Glickman SW; Rasiel EB; Hamilton CD; Kubataev A; Schulman KA
Science; 2006 Mar; 311(5765):1246-7. PubMed ID: 16513969
[No Abstract] [Full Text] [Related]
17. Charging for investigational drugs under an investigational new drug application. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2009 Aug; 74(155):40871-900. PubMed ID: 19691172
[TBL] [Abstract][Full Text] [Related]
18. Drug safety sciences and the bottleneck in drug development.
Watkins PB
Clin Pharmacol Ther; 2011 Jun; 89(6):788-90. PubMed ID: 21593756
[TBL] [Abstract][Full Text] [Related]
19. The right to a trial: Should dying patients have access to experimental drugs?
Groopman J
New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539
[No Abstract] [Full Text] [Related]
20. Drug development costs when financial risk is measured using the Fama-French three-factor model.
Vernon JA; Golec JH; Dimasi JA
Health Econ; 2010 Aug; 19(8):1002-5. PubMed ID: 19655335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
